Acquisition / mergerFiled on BSE ·
Kronox Lab Sciences Ltd: Completion of 64.26% share transfer and promoter change
Kronox Lab Sciences Ltd · Chemicals & Petrochemicals
What the filing says
- On September 29, 2026, 2,38,44,000 equity shares (64.26%) were transferred from Sellers to Indo Borax & Chemicals Ltd (Acquirer)
- Acquirer gained control and promoter status; Sellers, holding 9.95%, and promoter group seek reclassification as public
- Acquirer and Zenrock Chemicals Pvt Ltd are conducting an open offer to acquire 95,70,000 shares (25.79%) per SEBI Takeover Regulations
Original filing
Intimation Under Regulation 31 (A) Of SEBI (LODR) Regulation, 2015
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue: Rank 1Margin: Rank 1
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Kronox Lab Sciences Ltd
Other acquisition / merger filings this fortnight
- Acquisition / mergerTPL Plastech LtdTPL Plastech Limited to merge with Time Technoplast Limited; share exchange ratio approved
- Acquisition / mergerTPL Plastech LtdTPL Plastech Limited approves merger with Time Technoplast Limited
- Acquisition / mergerNiyogin Fintech LtdNiyogin Fintech schedules meetings for Scheme of Arrangement on Oct 30, 2026
- Acquisition / mergerVasa DenticityVasa Denticity Ltd cancels proposed 31.08% acquisition in IDS Denmed Pvt Ltd
- Acquisition / mergerIndo Borax & Ch.Indo Borax & Chemicals Ltd completes acquisition of 64.26% in Kronox Lab Sciences Ltd
- Acquisition / mergerHEG Advanced Materials LtdHEG Advanced Materials Limited announces cost of acquisition apportionment post-demerger
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
